0.06Open0.06Pre Close0 Volume9.28K Open Interest58.00Strike Price0.00Turnover302.41%IV26.59%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.0142Delta0.0031Gamma1315.50Leverage Ratio-0.2232Theta0.0000Rho-18.62Eff Leverage0.0014Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet